HCPLive
Digestive Disease Week 2013

Digestive Disease Week 2013 | DDW 2013

Recognized as one of the top 50 medical meetings by the Healthcare Convention & Exhibitors Association, Digestive Disease Week® (DDW) is the world's leading educational forum for academicians, clinicians, researchers, students and trainees working in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields.

Conference Coverages

Weight Loss Improves GERD Symptoms
Weight Loss Improves GERD Symptoms
Obese and overweight adults can improve symptoms of gastroesophageal reflux disease (GERD) by losing weight, while regaining even small amounts of weight can worsen symptoms.
Vitamin D May Improve Aspects of Crohn's Disease
For patients with stable Crohn's disease, vitamin D supplementation is associated with improvements in hand-grip strength, fatigue, and quality of life.
Full-Spectrum Beats Forward-Viewing in Colonoscopy
Use of a Full-Spectrum Endoscopy (FUSE) colonoscope is associated with increased polyp and adenoma detection rates and lower miss rates, compared with traditional forward-viewing (TFV) colonoscope.
TEMPO Trial Finds Transoral Incisionless Fundoplication Superior to Proton Pump Inhibitors in Some GERD Patients
Transoral incisionless fundoplication (TIF) was shown to be more effective than taking the maximal proton pump inhibitor (PPI) dose in relieving heartburn, regurgitation, and other troublesome symptoms in patients with refractory gastroesophageal reflux disease (GERD).
Researcher Sorts Through Sea of IBS Remedies
As irritable bowel syndrome (IBS) remains a complicated condition to treat with an etiology that’s still unknown, it’s difficult for physicians to find the best proven therapies among new remedies and the variety of pharmacological and nondrug options they have been trying for years.
Colonoscopy Prevents Crohn's Disease Post-Operative Endoscopic Recurrence
While it’s already clinically understood that most patients with Crohn’s disease suffer a recurrence following an intestinal resection, researchers have not evaluated the best strategy to prevent the disease from recurring.
Abdominal, Bowel Symptom Improvement From Linaclotide Meets FDA Standards for IBS-C
Patients taking linaclotide experience clinically meaningful improvement in abdominal and bowel symptoms, which closely correlate with the US Food and Drug Administration’s new criteria for irritable bowel syndrome with constipation (IBS-C).

Most Popular

$vacMongoViewPlus$ $vAR$